These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2905162)

  • 1. Terazosin (Hytrin): cumulative experience of clinical trials in the USA for the treatment of mild to moderate essential hypertension.
    Pool JL; Nelson EB; Taylor AA; Mitchell JR
    Br J Clin Pract Suppl; 1987 Dec; 54():9-14. PubMed ID: 2905162
    [No Abstract]   [Full Text] [Related]  

  • 2. Terazosin in mild hypertension: experience in open trials.
    Rosenthal J
    Br J Clin Pract Suppl; 1987 Dec; 54():32-44. PubMed ID: 2905160
    [No Abstract]   [Full Text] [Related]  

  • 3. Terazosin: a new alpha 1-blocker for the treatment of hypertension: a review of randomized, controlled clinical trials of once-daily administration as monotherapy.
    Luther RR; Glassman HN; Sperzel WD; Steinberg FJ; Horton JK; Jordan DC
    J Hypertens Suppl; 1986 Dec; 4(5):S494-7. PubMed ID: 2883273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terazosin for hypertension.
    Med Lett Drugs Ther; 1987 Dec; 29(755):112-3. PubMed ID: 2891021
    [No Abstract]   [Full Text] [Related]  

  • 5. [The use of terazosin hydrochloride (Hytrin) in the treatment of patients with benign prostatic hyperplasia].
    Sivkov AV; Apolikhin OI; Medvedev AA
    Urol Nefrol (Mosk); 1997; (5):50-3. PubMed ID: 9412019
    [No Abstract]   [Full Text] [Related]  

  • 6. Terazosin for BPH.
    Jerant AF
    J Fam Pract; 1995 Mar; 40(3):222-3. PubMed ID: 7533204
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of enalapril and terazosin on lipid metabolism in patients with essential arterial hypertension and accompanying hypercholesterolemia].
    Ponikowski P; Hańczycowa H; Sebzda T; Jurga M; Spring A; Rotter A; Jordanek P
    Wiad Lek; 1993 Apr; 46(7-8):250-4. PubMed ID: 7902632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of short-term selective alpha 1-adrenergic blockade with terazosin in patients with essential hypertension.
    Beretta-Piccoli C; Ferrier C; Weidmann P
    J Hypertens Suppl; 1985 Dec; 3(3):S231-4. PubMed ID: 2908818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terazosin: a new alpha adrenoceptor blocking drug.
    Achari R; Laddu A
    J Clin Pharmacol; 1992 Jun; 32(6):520-3. PubMed ID: 1353083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing and usage patterns of two antihypertensive agents: a comparison of terazosin and enalapril.
    Toiber F; Murthy VS
    Hosp Formul; 1991 Oct; 26(10):811-3, 817-8. PubMed ID: 10136554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
    Itskovitz HD
    Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pressure and metabolic effects of terazosin in essential hypertension].
    Valle R; Semplicini A; Serena L; Gebbin A; Fontebasso A; Gerardi G; De Toni R; Pessina AC
    Cardiologia; 1994 Jun; 39(6):421-4. PubMed ID: 7923256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between terazosin dose and blood pressure response in hypertensive patients.
    Achari R; Hosmane B; Bonacci E; O'Dea R
    J Clin Pharmacol; 2000 Oct; 40(10):1166-72. PubMed ID: 11028256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharma-clinics. Drug of the month. Terazosine (Hytrin)].
    Scheen AJ
    Rev Med Liege; 1995 Dec; 50(12):540-1. PubMed ID: 8570996
    [No Abstract]   [Full Text] [Related]  

  • 15. Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension.
    Titmarsh S; Monk JP
    Drugs; 1987 May; 33(5):461-77. PubMed ID: 2885169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of terazosin in the treatment of essential hypertension in blacks.
    Luther RR; Klepper MJ; Maurath CJ; Glassman HN; Achari R; Laddu AR
    J Hum Hypertens; 1990 Apr; 4(2):151-3. PubMed ID: 1971027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First European review of terazosin. Proceedings of a symposium. Reykjavik, Iceland, 29th-31st May 1987.
    Br J Clin Pract Suppl; 1987 Dec; 54():1-69. PubMed ID: 2905157
    [No Abstract]   [Full Text] [Related]  

  • 18. [Amlodipine combined with terazosin reduces postvoid residual and the risk of acute urinary retention].
    Yang C; Li YL; Fang J; Zhang X; Liu HP; Qin XH; Xu XP
    Zhonghua Nan Ke Xue; 2009 May; 15(5):441-4. PubMed ID: 19514558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terazosin: a new long-acting alpha 1-adrenergic antagonist for hypertension.
    Frishman WH; Eisen G; Lapsker J
    Med Clin North Am; 1988 Mar; 72(2):441-8. PubMed ID: 2894488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of terazocin on hypertensive patients].
    Liu G
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Oct; 18(5):271-2. PubMed ID: 1982259
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.